Outcomes research in surgical oncology

Annals of Surgical Oncology

Volumn 7, Issue 5, 2000, Pages 367-375

  Porter, Geoffrey A ^a   Skibber, John M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Outcomes; Quality of life; Review; Surgical oncology

Indexed keywords

ARTICLE; HEALTH CARE COST; HEALTH CARE QUALITY; MORBIDITY; MORTALITY; ONCOLOGY; OUTCOMES RESEARCH; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0034044876     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0367-4     Document Type: Article

References (75)

1. Oxford English Dictionary. Oxford: Oxford University Press, 1999.
2. Kane RL. Approaching the outcomes question. In: Kane R, ed. Understanding Health Care Outcomes Research. Gaithersburg, MD: Aspen Publications, 1997:1-16.
3. Donabedian A. Evaluating the quality of medical care. Milbank Memorial Fund Q 1966;XLIV:166-206.
4. World Health Organization. World Health Organization Constitution. Geneva: World Health Organization, 1948.
5. Karnofsky DA, Abelman WH, Craver LF, Burchenal JH. The use of nitrogen mustards in palliative treatment of carcinoma. Cancer 1998;1:632-56.
6. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-26.
7. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1996;319:1220-1.
8. Ellwood PM. Shattuck lecture: outcomes management: a technology of patient experience. N Engl J Med 1988;318:1549-56.
9. Woolf SH. Practice guidelines: a new reality in medicine: recent developments. Arch Intern Med 1990;150:1811-8.
10. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programs. New York: Oxford University Press, 1987.
11. Soloniuk L, McPeek B. Do the pluses outweigh the minuses? Theor Surg 1988;2:209-14.
12. Iezzoni LI. Using administrative diagnostic data to assess the quality of hospital care. Int J Technol Assess Health Care 1990; 6:272-81.
13. Paul JE, Weis KA, Epstein RA. Data bases for variations research. Med Care 1993;31:S96-S102.
14. Cook DJ, Mulroy CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126: 376-80.
15. Gerszten PC. Outcomes research: a review. Neurosurgery 1998; 43:1146-56.
16. Wennberg JE, Gittelson A. Small area variations in health care delivery. Science 1973;182:1102-8.
17. Birkmeyer JD, Welch HG. A reader's guide to surgical decision analysis. J Am Coll Surg 1997;184:589-95.
18. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston: Butterworth, 1988.
19. Finlayson SRG, Birkmeyer JD. Cost-effectiveness analysis in surgery. Surgery 1998;123:151-6.
20. Gold MR, Seigel JE, Russell LB, Weinstein MC. Cost-Effectiveness Analysis in Health and Medicine. New York: Oxford University Press, 1996.
21. Anonymous. Proceedings of the advances in health assessment conference: discussion panel. J Chron Dis 1987;40:S183-S191.
22. Lohr KN. Outcome measurement: concepts and questions. Inquiry 1988;25:37-50.
23. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 1996.
24. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA 1989;262: 925-30.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care 1992;30:473-83.
26. Roos LL, Sharp SM, Cohen MM. Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol 1991;44:881-8.
27. Kiezak SM, Flanders WD, Kosinski AS, Shipp AS, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 1999;52:137-42.
28. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997;50:725-33.
29. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
30. Menck HR, Cunningham MP, Jessup JM, et al. The growth and maturation of the National Cancer Data Base. Cancer 1997;80: 2296-304.
31. Menck HR, Bland KI, Scott-Conner CEH, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society: regional diversity and breadth of the National Cancer Data Base. Cancer 1998;83:2649-58.
32. Wennberg JE, Gittelson A. Variations in medical care among small areas. Sci Am 1982;246:120-34.
33. Wennberg JE, Freeman JL, Culp WJ. Are hospital services rationed in New Haven or overutilized in Boston? Lancet 1982;23: 1185-9.
34. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med 1989;321:1168-73.
35. Hannan EL, O'Donnell JF, Kilburn H, Bernard HR, Yazici A. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA 1989;262:503-10.
36. Pearce WH, Parker MA, Feinglass J, Ujiki M, Manheim LM. The importance of surgeon volume and training in outcomes for vascular surgical procedures. J Vasc Surg 1999;29:768-78.
37. Sainsbury JRC, Rider L, Smith A, et al. Does it matter where you live? Treatment variation for breast cancer in Yorkshire. Br J Cancer 1995;71:1275-8.
38. Sainsbury R, Haward B, Rider L, et al. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995;345:1265-70.
39. Matthews HR, Powell DJ, McConkey CC. Effects of the results of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg 1986;73:621-3.
40. Yeo CJ, Cameron JL, Maher MM. A prospective randomized controlled trial of pancreaticogastrostomy versus pancreaticojejunostomy. Ann Surg 1995;222:580-8.
41. Birkmeyer JD, Finlayson SRG, Tosteson ANA, et al. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250-6.
42. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227: 157-67.
43. McCardle CS, Hole D. Impact of variability among surgeons on postoperative mortality and morbidity and ultimate survival. BMJ 1991;302:1501-5.
44. Phillips RS, Hittinger R, Blesovsky L, et al. Local recurrence following curative surgery for large bowel cancer. Br J Surg 1984;71:17-20.
45. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
46. Simons AJ, Ker R, Groshen S, et al. Variations in treatment of rectal cancer: the influence of hospital type and caseload. Dis Colon Rectum 1997;40:641-6.
47. Holm T, Johansson H, Cedermark B, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997; 84:657-63.
48. Armitage P, Berry G. Statistical Methods In Medical Research. London: Blackwell Science, 1997.
49. Wong JH, Lubkey TB, Suarez-Almazor ME, Findlay JM. Improving the appropriateness of carotid endarterectomy: results of a prospective city-wide study. Stroke 1999;30:12-5.
50. Cella DF, Bonomi AE. Measuring quality of life. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD, eds. Cancer Management: A Multidisciplinary Approach. Huntington: RRR Inc., 1996:773-87.
51. Campbell A. The Sense of Well-Being in America: Recent Patterns and Trends. New York: McGraw-Hill, 1981.
52. McHorney CA, Ware JE, Rachel JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. MedCare 1994;32:40-66.
53. Revicki DA. Assessing health-related quality of life in clinical trials and practice settings: an overview. In: Perry MC, ed. Educational Book. Denver: American Society of Clinical Oncology, 1997:350-2.
54. Chambers LW. The McMaster Health Index Questionnaire: an update. In: Walker SR, Rosser RM, eds. Quality of Life Assessment: Key Issues in the 1990s. Dordrecht: Kluwer Academic, 1993:131-49.
55. Bergner M, Bobbitt RA, Carter WB, Gibson BS. The Sickness impact Profile: development and final revision of a health status measure. Med Care 1981;8:787-805.
56. Hunt SM, McKenna SP, McEwan JA. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 1980;34:281-5.
57. Parkerson GR, Broadhead WE, Tse CKJ. The Duke Health Profile: a 17-item measure of health and dysfunction. Med Care 1990;28: 1056-69.
58. Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Well-Being Scale: applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989;27:S27-S43.
59. Nelson EC, Berwick DM. The measurement of health status in clinical practice. Med Care 1989;27:S77-S90.
60. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981;34:585-97.
61. Patrick D, Deyo R. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1990;28: 1056-69.
62. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-83.
63. Finkelstein DM, Cassileth BR, Bonomi PD, et al. A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients: an Eastern Cooperative Oncology Group study. Am J Clin Oncol 1988;11:630-3.
64. Burris JA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
65. Tannock IF, Osaba D, Stockler MR, et al. Chemotherapy with mitoxane plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative endpoints. J Clin Oncol 1996;14:1756-64.
66. Torrance G, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
67. Feeny D, Torrance G. Incorporating utility-based quality-of-life measures in clinical trials. Med Care 1989;27:S190-S204.
68. Froberg DG, Kane RL. Methodology for measuring health-state preferences: I. Measurement strategies. J Clin Epidemiol 1989;42: 345-54.
69. Weeks J. Measurement of utilities and quality-adjusted survival. Oncology 1996;9:S67-S70.
70. Turner S. Quality-adjusted life years: cost-effective medical decision-making. J Cardiovasc Manag 1997;8:34-9.
71. Mully A. Assessing patient's utilities: can the ends justify the means? Med Care 1989;27:S269-S281.
72. Weeks JC, O'Leary J, Fairclough D, Paltiel D, Weinstein M. The "Q-tility index": a new tool for assessing health-related quality of life and utilities in clinical trials and clinical practice (abstract). Proc Am Soc Clin Oncol 1994;13:436.
73. Weeks J. Assessing utilities for health states. In: Perry MC, ed: Educational Book. Denver: American Society of Clinical Oncology, 1997:353-5.
74. Pettiti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. New York: Oxford University Press, 1994.
75. Temple LKF, Naimark D, McLeod R. Decision analysis as an aid to determining the management of early low rectal cancer for the individual patient. J Clin Oncol 1999;17:312-8.